In Lyme disease, hesitation can be more dangerous than treatment — the real risk is doing nothing.
Description
👉 Have you faced delays in Lyme disease treatment? Comment below.
Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma.
The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and manageable, while the risks of inaction include permanent neurologic damage, arthritis, cardiac issues, and even death.
The path forward lies in shared decision-making, individualized care, and supporting physicians so they feel safe providing thoughtful, evidence-based treatment. Ultimately, patient welfare must come before professional hesitation.
#LymeDisease #LymeWarrior #ChronicLyme #LymeAwareness #PatientStories
United States
